High-dose intravenous IgG for treatment of severe surgical infections

Digestive Surgery

Volumn 13, Issue 4-5, 1996, Pages 430-434

  Dominioni, Lorenzo ^a   Bianchi, Valentina ^a   Imperatori, Andrea ^a   Minoia, Giulio ^a   Dionigi, Renzo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

IgG; Immunoglobulin therapy; Sepsis; Sepsis score; Septic shock; Surgical infections

Indexed keywords

IMMUNOGLOBULIN G; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEPSIS; SURGICAL INFECTION; SURGICAL PATIENT;

EID: 0029790589     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000172479     Document Type: Article

References (21)

1. Fry DE, Pcarlstcin L, Fulton RL, Polk HC; Multiple system organ failure, Arch Surg 1980: 115:136-140.
2. Dominioni L, Dionigi R: The grading of sepsis and the assessment of its prognosis in the surgical patient: A review, Surg Res Comrnun 1987;1:1-11.
3. Marshall JC, Christou NV, Horn R, Meakins JL: The microbiology of multiple organ failure, Arch Surg 1988:123:309-315.
4. Dominioni L, Dionigi R, Zanello M, Chiaran-da M, Dionigi R, Acquarolo A, Ballabio A, Sguotti C: Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater, Arch Surg 1991:126:236-240.
5. Elcbute EA, Stonerl IB: The grading of sepsis, Br J Surg 1983;70:29-31.
6. Fisher G: Functional antibacterial activity of a human intravenous immunoglobulin preparation: In vitro and in vivo studies, Vox Sang 1983:44:262-299.
7. Van Furth R, Leigh PCJ, Klein F: Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use, Rev Infect Dis 1984:149:511-517.
8. Dominioni L, Gennari R, Interdonato PF, Fes-li L, Galozzi R, Dionigi R: Effects of high-dose polyvalent IgG on defective bacterial phagocytosis in severe surgical sepsis, Surg Res Com-mun 1993;14:103-109.
9. Pollack M: Antibody activity againstPseudomonas aeruginosain immunoglobulins prepared for intravenous use in humans, Rev Infect Dis 1983;147:1090-1098.
10. Shennib H, Richards JK, Mulder DS: Role of adjuvant immunoglobulin in the treatment of abdominal sepsis in a rat model, Surg Res Commun 1989:6:89-95.
11. Schedel L. Dreikhausen U, Nentwig B, Hock-enschneidcr M, Rauthmann D, Balikcioglu S, Coldcwav R, Deicher H: Treatment of gram-negative septic shock with an immunoglobulin preparation: A prospective, randomized clinical trial, Crit Care Med 1991:19:1104-1113.
12. Ohmann C, Quick P: Surgical Infection Society Europe: Computerized information system, Discussion about the trial protocol of supplemental immunoglobulin therapy in sepsis and septic shock, TheorSurg 1993:8:61-63.
13. Dionigi R, Dominioni L, Jemos V: Sepsis score and complement factor B for monitoring severely septic surgical patients and for predicting their survival, Eur Surg Res 1985:17:269-280.
14. Gamer JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. J Infect Control 1988:16:128-140.
15. Horan TC, Gaynes RP, Martonc WJ, Jarvis WR, Emori TG: CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections, Infect Control Hosp Epidemiol 1992:13:606-608.
16. Glinz W, Grob PJ, Nydegger UE, Ricklin T, Stamm F, Stoffel D, Lasance A: Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma - A randomized, placebo-controlled study, IntensiveCare Med 1985:11:288-294.
17. Mao P, Enrichcns F, Olivcro G, Festa T, Benedetto G, Sciatscia C, Visetli E, Mauri A, Oli-vero S: Early administration of intravenous immunoglobulins in the prevention of surgical and post-traumatic sepsis: A double blind randomized clinical trial, Surg Res Commun 1989;5:93-98.
18. Lehmkuhl P, Jeck-Thole S, Dellbrugge J, Pichl-mayr I: Effects of immune globulins given following major intraabdominal surgery, Fortschr Anasthesio! Notfall Intensivmed 1990;4:48-52.
19. The Intravenous Immunoglobulin Collaborative Study Group: Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of post-surgical infection, N Engl J Med 1992:327: 234-240.
20. Caficro F, Gipponi M, Bonalumi U, Piccardo A, Sguotti C, Corbetta G: Prophylaxis of infection with intravenous immunoglobulins plus antibiotic for patients at risk for sepsis undergoing surgery for colorectal cancer: Results of a randomized, multicenter clinical trial, Surgery 1992:112:24-31.
21. Dominioni L, lmperatori A, Gennari R, Dionigi R: High-dose immunoglobulins for prophylaxis of severe sepsis; in Engemann R, Holz-heimcr R, Thiede A (eds): Immunology and Its Impact on Infections in Surgery, Berlin, Springer, 1995. pp 203-207.